Clinical Research Directory
Browse clinical research sites, groups, and studies.
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
Sponsor: Synbiotic Health
Summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Official title: VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-02
Completion Date
2027-01
Last Updated
2026-02-27
Healthy Volunteers
Yes
Conditions
Interventions
Bifidobacterium adolescentis iVS-1
B. adolescentis iVS-1 (probiotic capsule) delivered orally once daily at a minimum of 8 billion CFU/day
Placebo
Placebo capsule delivered orally once daily
Locations (1)
MusB Research LLC
New Port Richey, Florida, United States